GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,000 | 0.0% | 205 | 0.0% | 0.02% | -16.7% |
| Q1 2019 | $35,000 | +75.0% | 205 | 0.0% | 0.02% | +38.5% |
| Q4 2018 | $20,000 | -60.0% | 205 | -29.3% | 0.01% | -56.7% |
| Q3 2018 | $50,000 | +117.4% | 290 | +75.8% | 0.03% | +20.0% |
| Q2 2018 | $23,000 | +35.3% | 165 | 0.0% | 0.02% | +92.3% |
| Q1 2018 | $17,000 | -22.7% | 165 | 0.0% | 0.01% | -18.8% |
| Q4 2017 | $22,000 | +22.2% | 165 | 0.0% | 0.02% | 0.0% |
| Q3 2017 | $18,000 | +5.9% | 165 | 0.0% | 0.02% | -11.1% |
| Q2 2017 | $17,000 | -10.5% | 165 | 0.0% | 0.02% | -10.0% |
| Q1 2017 | $19,000 | -5.0% | 165 | 0.0% | 0.02% | -25.9% |
| Q4 2016 | $20,000 | – | 165 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |